EyeYon Medical’s EndoArt Heads to U.S. Clinical Trial After FDA IDE Approval
A synthetic sliver that could upend corneal edema care in the U.S.—no donor required. EndoArt (EyeYon Medical; Ness Ziona, Israel)…
Topcon Healthcare’s OMNIA Gets FDA 510(k) Clearance, Hits U.S. Market
FDA-approved and U.S.-bound: OMNIA is hitting the market as an all-in-one pretesting solution. Topcon Healthcare (Tokyo, Japan) has earned U.S….
latest posts
